Navigation Links
Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
Date:5/21/2013

re randomized to receive simeprevir or placebo for 12 weeks plus pegylated interferon and ribavirin for 24 or 48 weeks. In findings related to a secondary endpoint, 93 percent of patients receiving simeprevir were able to shorten therapy with pegylated interferon and ribavirin to 24 weeks as a result of meeting response-guided therapy criteria. Eighty-three percent of those patients meeting response-guided therapy criteria to stop treatment at 24 weeks achieved SVR12.

Patients enrolled in PROMISE were stratified by hepatitis C virus (HCV) genotype 1 subtype and IL28B genotype. SVR12 rates among patients treated with simeprevir according to IL28B genotype were 89 percent for the CC allele, 78 percent for the CT allele, and 65 percent for the TT allele, compared to 53 percent for the CC allele, 34 percent for the CT allele and 19 percent for the TT allele in the placebo arm. Among patients with METAVIR scores F0 to F2, 82 percent of patients treated with simeprevir and 41 percent with placebo achieved SVR12. Among patients with METAVIR scores F3 and F4, 73 percent and 74 percent of patients treated with simeprevir and 20 percent and 26 percent treated with placebo achieved SVR12, respectively. The METAVIR score is used to quantify the degree of inflammation and fibrosis of the liver and patients are scored on a five-point scale. 

"Janssen is pleased to share the primary endpoint results from PROMISE with the scientific community alongside primary data from our Phase 3 QUEST-1 and QUEST-2 studies of simeprevir, which are also being presented at DDW," said Maria Beumont , M.D., medical leader for simeprevir, Janssen. "We now have robust data for simeprevir in both treatment-experienced and treatment-naïve patients that demonstrate primary efficacy and safety in patients with genotype 1 chronic hepatitis C."

The most common adverse events seen in patients receiving simeprevir versus placebo in
'/>"/>

SOURCE Janssen R&D Ireland
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor
2. Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival
3. Healthscope to commercially launch Circadians Cancers of Unknown Primary Diagnostic Test
4. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
5. Lilly Announces Pomaglumetad Methionil Did Not Meet Primary Endpoint of Clinical Study
6. Jeffrey Modell Foundation Opens Diagnostic Center for Primary Immunodeficiencies at Midwest Immunology Clinic
7. MultiCell Technologies Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in vitro Models
8. GeneTex, Inc. to Launch a New Primary Antibody against HIF1a
9. Albireo Has Been Granted Orphan Drug Designation for A4250 from the US FDA for the Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) and for Primary Biliary Cirrhosis (PBC)
10. AcelRx Announces Achievement of the Primary End-Point in Phase 3 Comparative Study Involving the Sufentanil NanoTab PCA System and Plans to Hold a Conference Call and Webcast Tomorrow to Discuss Top-Line Results
11. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... TWINSBURG, Ohio , Aug. 31, 2015 /PRNewswire/ ... and applications, has acquired MACTek Corporation, a leading ... part of Pepperl+Fuchs, strategy to further extend its ... the WirelessHART market.    "We are ... to our existing portfolio," said Jim Bolin ...
(Date:8/31/2015)... 2015 Thousands of people will peacefully demonstrate ... opioid addiction epidemic at dozens of rallies across the ... the United States has experienced ... opioids and heroin, yet the President has never once ... letter to President Obama , rally organizers compared ...
(Date:8/31/2015)... , August 31, 2015 ... the global cardiovascular monitoring and diagnostic devices market ... predicted to reach a value of approximately US$7.0 ... 9.7% between 2013 and 2019. The title of ... Market (ECG, Holter Monitors, Event Monitors, Cardiovascular Diagnostic ...
Breaking Medicine Technology:Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5
(Date:8/31/2015)... ... 31, 2015 , ... Three Bakers Gluten Free Bakery launched the redesign of ... and easy-to-find information on their offering of gluten-free breads and pizzas, living without gluten, ... way for us to share information about our gluten free product offerings, but also ...
(Date:8/31/2015)... ... August 31, 2015 , ... Finnleo is pleased ... Terrace Outdoor Sauna. After months of extensive engineering and design of our newest sauna ... withstand the elements and is offered at a very attractive price-point. , Before ...
(Date:8/31/2015)... ... August 31, 2015 , ... DR. LUCIANA ON ... (aka Dr. Luciana) received a total of three Silver Medal awards at ... Best (Dis)ability Film. Dr. Luciana co-wrote and co-produced this pilot with Del Weston, ...
(Date:8/31/2015)... ... 31, 2015 , ... American Family Care (AFC), the nation’s ... presence in Tennessee with the opening of a new urgent care facility at ... sixteenth in Tennessee, and 148th in the U.S. overall. , “We’re excited to ...
(Date:8/31/2015)... ... , ... The more hours young adults spend watching television each day, the ... circumference, a 15-year analysis by the University of Pittsburgh Graduate School of Public Health ... young adulthood is an important time to intervene and promote less television viewing, according ...
Breaking Medicine News(10 mins):Health News:Three Bakers Gluten Free Bakery Announces Launch of New Website 2Health News:Say “Hello” to the Brand New Finnleo Terrace Outdoor Saunas 2Health News:Actor/Writer/Director/Psychology Professor Luciana Lagana Receives Three Wins at the 2015 Global Independent Film Awards for the TV Pilot Dr. Luciana on Aging and Falling 2Health News:State-of-the-Art Urgent Care Facility Opening in Knoxville 2Health News:Watching More TV as a Young Adult Predicts Obesity 2Health News:Watching More TV as a Young Adult Predicts Obesity 3
... by a New York University dental research team has ... are more likely to develop gestational diabetes mellitus than ... study, led by Dr. Ananda P. Dasanayake, a professor ... of Dentistry, followed 256 women at New Yorks Bellevue ...
... neurons that were genetic match improved symptoms, avoided ... Therapeutic cloning successfully treated Parkinson,s disease in mice, ... dopamine-producing neurons with an identical genetic profile to ... improve the neurological performance of the diseased animals, ...
... FARMINGTON HILLS, Mich., March 24 During National Root,Canal ... part series of articles,is available for publication courtesy of ... for aging, facts about,root canals and new technology that ... heart?, Dental health can affect your overall health, ...
... March 24 Sharps Compliance Corp.,(OTC Bulletin Board: ... disposal solutions for small quantity generators of,medical waste, ... the,position of Senior Vice President of Operations. Mr. ... ("GMD"), a developer and,manufacturer of medical devices, where ...
... where teens go when not in or near home or ... health-related behavior such as smoking or sexual activity" The answer ... , In a paper published in the April issue ... School of Medicine report on a pilot study which evaluated ...
... Accepts as Complete DNV,s ... Hospital Deeming Authority, HOUSTON, March 24 The U.S. ... that its application to,deem hospitals in compliance with the Medicare ... formal review., If approved, DNV stands to become the ...
Cached Medicine News:Health News:NYU dental researchers find evidence of periodontal disease leading to gestational diabetes 2Health News:Therapeutic Cloning Works in Mice With Parkinson's 2Health News:Therapeutic Cloning Works in Mice With Parkinson's 3Health News:Watch Your Mouth: Michigan Association of Endodontists Offers Four Part Series on Keeping Your Teeth Healthy 2Health News:Watch Your Mouth: Michigan Association of Endodontists Offers Four Part Series on Keeping Your Teeth Healthy 3Health News:Watch Your Mouth: Michigan Association of Endodontists Offers Four Part Series on Keeping Your Teeth Healthy 4Health News:Watch Your Mouth: Michigan Association of Endodontists Offers Four Part Series on Keeping Your Teeth Healthy 5Health News:Watch Your Mouth: Michigan Association of Endodontists Offers Four Part Series on Keeping Your Teeth Healthy 6Health News:Sharps Compliance Corp. Announces Appointment of Al Aladwani as its Senior Vice President of Operations 2Health News:Sharps Compliance Corp. Announces Appointment of Al Aladwani as its Senior Vice President of Operations 3Health News:Risky teen behavior may not occur at home or school: but how to track? 2Health News:DNV Healthcare Advances in Bid to Accredit Hospitals 2
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
The HT-PB is a implantable bipolar tined permanent pacing lead for stimulation of the ventricle....
... Flextend lead is a ... with an extendable/retractable active-fixation ... design offers various lead ... implantation in the atrium ...
The RU is a low profile implantable bipolar tined permanent pacing lead for stimulation of either the atrium (J model) or the ventricle (straight model)....
Medicine Products: